[144] The Brink's Company SEC Filing

Rhea-AI Filing Summary

The filing is a Form 144 for The Brink's Company (BCO) notifying of a proposed sale of 21,700 common shares through Merrill Lynch with an aggregate market value of $2,379,907.00. The filer reports 41,662,286 shares outstanding and an approximate sale date of 08/15/2025 on the NYSE. The shares were acquired through the company’s stock plan on four dates: 6/30/2023 (3,183 shares), 3/3/2024 (877), 6/30/2024 (2,551), and 2/19/2025 (15,089). No securities were reported sold by the filer in the past three months. The filer attests there is no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: This is a routine insider sale notice disclosing planned disposition of 21,700 shares via a broker on a stated date.

The Form 144 provides required disclosure for an intended sale under Rule 144: number of shares, aggregate market value, broker, estimated sale date, and acquisition history by lot. The disclosed lots show most shares were acquired recently through the issuer's stock plan, including a large lot on 02/19/2025. The absence of reported sales in the past three months suggests this is not part of a recent active selling pattern. For investors, the filing documents the mechanics of a proposed sale but contains no operational or financial data about the issuer.

Corporate Governance Expert

TL;DR: Filing complies with Rule 144 procedural requirements and includes the attestation regarding undisclosed material information.

The notice lists the broker, share counts, acquisition dates, and confirms no material nonpublic information is known to the seller. This attestation is standard and important for insider compliance. The transaction appears to be executed through a major broker on a public exchange, indicating standard market disposition rather than a private transfer. No governance events, officer departures, or related-party transaction details are provided in this form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 1800 K St NW, Suite 800 Washington DC 20006	21700	2379907.00	41662286	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2023	Stock plan activity	Issuer			3183	06/30/2023	N/A
Common	03/03/2024	Stock plan activity	Issuer			877	03/03/2024	N/A
Common	06/30/2024	Stock plan activity	Issuer			2551	06/30/2024	N/A
Common	02/19/2025	Stock plan activity	Issuer			15089	02/19/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Form 144 for The Brink's Company (BCO) disclose?

The filing discloses a proposed sale of 21,700 common shares via Merrill Lynch with an aggregate market value of $2,379,907.00 and an approximate sale date of 08/15/2025.

How many shares of BCO are outstanding per the Form 144?

The filer reports 41,662,286 shares outstanding.

When and how were the shares being sold acquired?

Shares were acquired through the issuer's stock plan on 06/30/2023 (3,183), 03/03/2024 (877), 06/30/2024 (2,551), and 02/19/2025 (15,089).

Did the filer sell any issuer securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Which broker will handle the proposed BCO share sale?

The sale is to be handled by Merrill Lynch, 1800 K St NW, Suite 800, Washington DC and is to occur on the NYSE.